NYSE$CYH

Community Health Systems Inc · Q4 2022 earnings

Q4 2022 earnings · · Investor relations

Briefing

Announced results for the fourth quarter and year ended December 31, 2022.

Community Health Systems, Inc. reported net operating revenues of $3.142 billion and net income attributable to Community Health Systems, Inc. stockholders of $414 million, or $3.18 per share (diluted), for the three months ended December 31, 2022. Adjusted EBITDA was $404 million, including $2 million of pandemic relief funds. On a same-store basis, admissions increased 4.4 percent and adjusted admissions increased 8.2 percent, compared to the same period in 2021.

  • Net operating revenues totaled $3.142 billion.
  • Net income attributable to Community Health Systems, Inc. stockholders was $414 million, or $3.18 per share (diluted).
  • Adjusted EBITDA was $404 million, including $2 million of pandemic relief funds.
  • Approximately $378 million principal amount of notes outstanding were extinguished during the three months ended December 31, 2022.

Headline financials

Total Revenue

$3.14B

Previous: $3.23B-2.8%
EPS (adj)

$1.50

Previous: $1.15+30.4%
Adjusted EBITDA

$404M

No prior period
Capital Expenditures

$131M

Previous: $135M-3.0%
Free Cash Flow

-$122M

Previous: -$666M+81.7%
Net Income

$446M

Previous: $223M+100.0%
Operating Income

$228M

Previous: $424M-46.2%
Gross Profit

$1.29B

Previous: $1.38B-6.4%
Cash & Equivalents

$118M

Previous: $507M-76.7%
Total Assets

$14.7B

Previous: $15.2B-3.6%
Stock-Based Comp

$6M

Previous: $7M-14.3%

Revenue & EPS history

CHS · Revenue · Quarterly

$3.14B

Q4 2022-2.8%vs Q4 2021
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Forward guidance

The Company’s projections exclude the effect of debt refinancing activities, impairment of goodwill and long-lived assets, previously recorded pandemic relief funds, the impact of any potential future divestitures, gains or losses from the sales of businesses, employee termination benefits and restructuring costs, resolution of government investigations or other significant legal settlements, costs incurred in connection with divestitures, and other significant gains or losses that neither relate to the ordinary course of business nor reflect the Company’s underlying business performance.

Tailwinds

  • Net operating revenues (in millions) $ 12,200 to $ 12,600
  • Adjusted EBITDA (in millions) $ 1,475 to $ 1,625
  • Net loss per share—diluted $ (0.65 ) to $ (0.05 )
  • Weighted-average diluted shares (in millions) 130.0 to 131.0
  • Capital expenditures are projected as follows (in millions): $450 to $500

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2022

Historical avgQ4 2022

+1.7%

Avg return

Earnings day

+3.6%

Avg return

5 days after

+2.4%

Avg return

30 days after

55%

38 / 69 earnings

Positive

+52.4%

Q4 2022

Best reaction

-41.0%

Q2 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.3%+6.3%+3.0%
Q4 2025+5.7%+4.5%-13.5%
Q3 2025+25.8%+29.1%-4.3%
Q2 2025+0.0%-0.7%+7.7%
Q1 2025+18.5%+11.1%+51.0%
Q4 2024+7.8%+9.9%-22.4%
Q3 2024-22.6%-25.3%-33.5%
Q2 2024+17.5%+27.9%+24.9%
Q1 2024+9.8%+11.1%+20.9%
Q4 2023-28.4%-27.7%-11.6%
Q3 2023-7.0%-18.0%+12.1%
Q2 2023+11.8%-8.4%-18.9%
Q1 2023-39.9%-42.3%-48.4%
Q4 2022+52.4%+56.3%-0.6%
Q3 2022+36.8%+35.4%+68.9%
Q2 2022-41.0%-39.6%-38.6%
Q1 2022-4.2%-19.1%-40.1%
Q4 2021-10.1%-21.3%-15.1%
Q3 2021+19.1%+28.9%+28.4%
Q2 2021-6.4%-8.3%-13.1%
Q1 2021+0.3%+15.2%+37.9%
Q4 2020-7.6%-9.3%+28.3%
Q3 2020+19.2%+30.3%+78.3%
Q2 2020+14.2%+26.4%+37.8%
Q1 2020-7.4%-22.9%-11.8%
Q4 2019+42.7%+27.8%-44.2%
Q3 2019-17.0%-30.4%-32.6%
Q2 2019+12.9%+25.8%+39.7%
Q1 2019-1.7%-4.0%-19.9%
Q4 2018+12.8%+21.4%+8.5%
Q3 2018-6.3%+20.0%+33.3%
Q2 2018+2.3%+9.5%+16.7%
Q1 2018+34.7%+26.5%+8.2%
Q4 2017-11.6%-15.0%-31.6%
Q3 2017-23.1%-26.6%-26.3%
Q2 2017-7.8%-8.8%+6.9%
Q1 2017+19.9%+11.7%+2.8%
Q4 2016+33.8%+33.6%+21.7%
Q3 2016+0.8%+4.9%+3.0%
Q2 2016-1.5%-0.5%-19.3%
Q1 2016-22.1%
Q4 2015-22.1%
Q3 2015-2.4%
Q2 2015+1.2%
Q1 2015-7.6%
Q4 2014+1.2%
Q3 2014-5.0%
Q2 2014-4.9%
Q1 2014-7.2%
Q4 2013+0.3%
Q3 2013-0.3%
Q2 2013+2.2%
Q1 2013+4.7%
Q4 2012+1.4%
Q3 2012+2.4%
Q2 2012-4.3%
Q1 2012+5.2%
Q4 2011+5.3%
Q3 2011-2.7%
Q2 2011-6.4%
Q1 2010-3.5%
Q1 2011+0.1%
Q4 2008+8.0%
Q4 2010+8.0%
Q3 2009+2.0%
Q3 2010+2.0%
Q4 2009+4.3%
Q2 2009+4.3%
Q2 2010+4.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro